Against the background that Fn14 is regularly expressed at high levels on tumor cells of non-hematopoietic origin but also on various cells of the tumor microenvironment (4, 5), it is considered as a promising target for cancer therapy. This evidence concerns the gene TNFRSF12A and neoplasm.